Shanghai Haohai Biological Technology Co., Ltd.

SHSC:6826 Stock Report

Market Cap: HK$14.0b

Shanghai Haohai Biological Technology Future Growth

Future criteria checks 3/6

Shanghai Haohai Biological Technology is forecast to grow earnings and revenue by 16.8% and 11.8% per annum respectively. EPS is expected to grow by 25.4% per annum. Return on equity is forecast to be 9.7% in 3 years.

Key information

16.8%

Earnings growth rate

25.4%

EPS growth rate

Biotechs earnings growth42.0%
Revenue growth rate11.8%
Future return on equity9.7%
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:6826 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,517638N/AN/A1
12/31/20253,153565N/AN/A1
12/31/20242,751478N/AN/A1
9/30/20242,747430325674N/A
6/30/20242,746446296679N/A
3/31/20242,689432239630N/A
12/31/20232,654416367634N/A
9/30/20232,53034699442N/A
6/30/20232,48731592401N/A
3/31/20232,263226-35254N/A
12/31/20222,130180-86231N/A
9/30/20222,06320352343N/A
6/30/20221,86119257336N/A
3/31/20221,80527264339N/A
12/31/20211,75035270342N/A
9/30/20211,702428115333N/A
6/30/20211,674434120342N/A
3/31/20211,594370N/AN/AN/A
12/31/20201,32423066262N/A
9/30/20201,343232-20258N/A
6/30/20201,3062166258N/A
3/31/20201,437279N/AN/AN/A
12/31/20191,595371-50349N/A
9/30/20191,537353-8286N/A
6/30/20191,570386-7302N/A
3/31/20191,478375N/AN/AN/A
12/31/20181,546415239391N/A
9/30/20181,523411235398N/A
6/30/20181,501408N/A404N/A
3/31/20181,423390N/A374N/A
12/31/20171,345372N/A343N/A
9/30/20171,214351N/A330N/A
6/30/20171,083329N/A317N/A
3/31/2017967317N/A286N/A
12/31/2016851305N/A254N/A
9/30/2016787295N/A245N/A
6/30/2016724284N/A235N/A
3/31/2016694279N/A252N/A
12/31/2015664273N/A269N/A
9/30/2015630258N/A244N/A
6/30/2015597243N/A219N/A
3/31/2015556213N/A181N/A
12/31/2014516184N/A142N/A
9/30/2014482169N/A135N/A
6/30/2014449154N/A128N/A
3/31/2014425148N/A137N/A
12/31/2013401142N/A147N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6826's forecast earnings growth (16.8% per year) is above the savings rate (2.3%).

Earnings vs Market: 6826's earnings (16.8% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).

High Growth Earnings: 6826's earnings are forecast to grow, but not significantly.

Revenue vs Market: 6826's revenue (11.8% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 6826's revenue (11.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 6826's Return on Equity is forecast to be low in 3 years time (9.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y